hypothyroidism
HYPOTHYROIDISM
Hypothyroidism is a common endocrine disorder where in the thyroid does not make enough thyroid hormone.
Subclinical/mild hypothyroidism refers to the state of slightly increased serum TSH with normal serum FT4 in patients who are usually asymptomatic.
Most common cause of primary hypothyroidism is autoimmune thyroiditis or Hashimoto's disease.
Levothyroxine is the first-line agent for treatment of hypothyroidism.

Laboratory Tests

Confirmation of hypothyroidism & differentiating between primary, central & subclinical hypothyroidism

  • Measure serum TSH: Most sensitive test for detecting hypothyroidism
  • Confirm w/ measurement of serum FT4
  • Primary hypothyroidism: High TSH & low FT4
  • Central hypothyroidism: Low/normal/mildly elevated TSH & low FT4
  • Subclinical hypothyroidism: High TSH & normal FT4

Other tests

  • Thyroid autoantibodies
    • Antithyroid peroxidase, antithyroglobulin autoantibodies
  • Thyroid scan, ultrasonography (may do both)

Subclinical / Mild Hypothyroidism

  • Subclinical hypothyroidism refers to the state of slightly increased serum TSH w/ normal serum FT4 in patients who are usually asymptomatic

Other causes of elevated TSH that should be excluded

  • Recent Levothyroxine dose adjustment wherein a steady state is not achieved
  • Transient increase in TSH during recovery from severe illness or destructive thyroiditis
  • Untreated primary adrenal insufficiency
  • Administration of recombinant human TSH
  • Presence of heterophilic antibodies against mouse proteins

Determination of Treatment for Subclinical Hypothyroidism:

Further Evaluation

  • Thyroid antibodies detection (if positive, for treatment); if negative (TSH >10 mU/L, for treatment)
  • Physical exam
  • Lipid profile

Risk Assessment

  • Higher risk of progression to overt hypothyroidism if TSH >10 mU/L, presence of thyroid antibodies, goiter, hyperlipidemia, pregnancy, ovulatory dysfunction w/ infertility
    • Treatment is recommended in higher risk patients
    • If patient is not at high risk, perform annual thyroid exam

Primary Hypothyroidism

Etiologies

Autoimmune Thyroiditis (Hashimoto’s Disease)

  • Most common cause
  • Diagnosis
    • Thyroid antibodies [anti-thyroid peroxidase (TPO)- in 95% or antithyroglobulin (TG) detection in 60%]
    • Careful history of radiation exposure, radioactive iodine therapy, neck surgery, recent viral infection, medications, pregnancy, change in diet
    • Presence of thyroid antibodies & absence of any of the above history confirms diagnosis of Hashimoto’s thyroiditis

Other Causes

  • Congenital: Endemic iodine deficiency (Athyreosis, dyshormonogenesis), thyroid hormone resistance, TSH-receptor defect
  • Acquired: Iodine deficiency, iatrogenic (post-thyroidectomy, thyroid irradiation, medications, radioactive iodine therapy)
  • Transient: Subacute thyroiditis (de Quervain’s), lymphocytic thyroiditis (silent, postpartum & painless thyroiditis), neonatal hypothyroidism

Central Hypothyroidism

Evaluation

  • Thorough exam of the function of the hypothalamic-pituitary axis
  • Determine adrenal status, if adrenal insufficient:
    • Thyroxine administration may increase metabolism & precipitate an adrenal crisis
    • Glucocorticoid should be replaced prior to thyroxine administration to avoid adrenal crisis

Etiologies 

  • Central hypothyroidism is divided into secondary hypothyroidism (defect is in the pituitary gland) & tertiary hypothyroidism (defect is in the hypothalamus)
  • Central hypothyroidism occurs due to failure of the hypothalamic-pituitary axis causing decreased TSH secretion or reduced TSH biological activity
  • Pituitary: Tumor, vascular insufficiency, empty sella syndrome, infiltrating disease, infection, iatrogenic (surgery & radiotherapy)
  • Hypothalamic: Tumor, infection, vascular insufficiency, thyrotropin-releasing hormone (TRH) deficiency, iatrogenic

Myxedema Coma

  • Correct diagnosis is imperative because critical illnesses are clinically similar to myxedema coma & can also present w/ altered thyroid function
    • If diagnosis is wrong, high doses of thyroid hormone is dangerous to the patient

Signs & Symptoms

  • Severe hypothermia (<27°C)
  • Bradycardia
  • Respiratory failure & loss of consciousness
  • Long-standing hypothyroidism

Precipitating Factors

  • Infection
  • CV event
  • Exposure to cold
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
25 Aug 2015
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
Roshini Claire Anthony, 07 Nov 2017

Women who are underweight, particularly in their late teens and mid-thirties, may be at risk for early menopause, a recent study found. 

16 Aug 2014

New drug applications approved by US FDA as of 15-30 Aug which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.